Gene · 57794
Papers4,188
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,781 to 1,800 of 4,188
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Circular RNAs: characteristics, biogenesis, mechanisms and functions in liver cancer. | J Hematol Oncol | 2021 | 34461958 | PubTator, text mining | PubMed |
| Transcriptional control of CBX5 by the RNA binding proteins RBMX and RBMXL1 maintains chromatin state in myeloid leukemia. | Nat Cancer | 2021 | 34458856 | PubTator, text mining | PubMed |
| Emerging Role of Circular RNA-Protein Interactions. | Noncoding RNA | 2021 | 34449657 | PubTator, text mining | PubMed |
| Liquid Biopsy for Cancer Cachexia: Focus on Muscle-Derived microRNAs. | Int J Mol Sci | 2021 | 34445710 | PubTator, text mining | PubMed |
| Role of High Voltage-Gated Ca2+ Channel Subunits in Pancreatic β-Cell Insulin Release. From Structure to Function. | Cells | 2021 | 34440773 | PubTator, text mining | PubMed |
| Circular RNA as An Epigenetic Regulator in Chronic Liver Diseases. | Cells | 2021 | 34440714 | PubTator, text mining | PubMed |
| hnRNP A/B Proteins: An Encyclopedic Assessment of Their Roles in Homeostasis and Disease. | Biology (Basel) | 2021 | 34439945 | PubTator, text mining | PubMed |
| Mechanisms Regulating Abnormal Circular RNA Biogenesis in Cancer. | Cancers (Basel) | 2021 | 34439339 | PubTator, text mining | PubMed |
| Insights into the Evolving Roles of Circular RNAs in Cancer. | Cancers (Basel) | 2021 | 34439334 | PubTator, text mining | PubMed |
| The RNA-Binding Protein ESRP1 Modulates the Expression of RAC1b in Colorectal Cancer Cells. | Cancers (Basel) | 2021 | 34439247 | PubTator, text mining | PubMed |
| The endogenous mex-3 3´UTR is required for germline repression and contributes to optimal fecundity in C. elegans. | PLoS Genet | 2021 | 34424904 | PubTator, text mining | PubMed |
| Immune Microenvironment Change and Involvement of Circular RNAs in TIL Cells of Recurrent Nasopharyngeal Carcinoma. | Front Cell Dev Biol | 2021 | 34422839 | PubTator, text mining | PubMed |
| Editorial: Computational Tools in Inferring Cancer Tissue-of-Origin and Molecular Classification Towards Personalized Cancer Therapy, Volume II. | Front Genet | 2021 | 34422025 | PubTator, text mining | PubMed |
| Systematic Analysis Identifies a Specific RNA-Binding Protein-Related Gene Model for Prognostication and Risk-Adjustment in HBV-Related Hepatocellular Carcinoma. | Front Genet | 2021 | 34422009 | PubTator, text mining | PubMed |
| Hsa_circ_0026628 promotes the development of colorectal cancer by targeting SP1 to activate the Wnt/β-catenin pathway. | Cell Death Dis | 2021 | 34420031 | PubTator, text mining | PubMed |
| Targeting Akt in cancer for precision therapy. | J Hematol Oncol | 2021 | 34419139 | PubTator, text mining | PubMed |
| From Pancreatic β-Cell Gene Networks to Novel Therapies for Type 1 Diabetes. | Diabetes | 2021 | 34417266 | PubTator, text mining | PubMed |
| Architecture and sequence stratigraphy of the Upper Coralline Limestone formation, Malta-Implications for Eastern Mediterranean restriction prior to the Messinian Salinity Crisis. | Depos Rec | 2021 | 34413980 | PubTator, text mining | PubMed |
| Comprehensive Characterization of RNA Processing Factors in Gastric Cancer Identifies a Prognostic Signature for Predicting Clinical Outcomes and Therapeutic Responses. | Front Immunol | 2021 | 34413861 | PubTator, text mining | PubMed |
| Matrix factorization-based data fusion for the prediction of RNA-binding proteins and alternative splicing event associations during epithelial-mesenchymal transition. | Brief Bioinform | 2021 | 34410342 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57794/papers?page=90